170 related articles for article (PubMed ID: 25047362)
1. Breast cancer risk in young women in the national breast screening programme: implications for applying NICE guidelines for additional screening and chemoprevention.
Evans DG; Brentnall AR; Harvie M; Dawe S; Sergeant JC; Stavrinos P; Astley S; Wilson M; Ainsworth J; Cuzick J; Buchan I; Donnelly LS; Howell A
Cancer Prev Res (Phila); 2014 Oct; 7(10):993-1001. PubMed ID: 25047362
[TBL] [Abstract][Full Text] [Related]
2. What are the benefits and harms of risk stratified screening as part of the NHS breast screening Programme? Study protocol for a multi-site non-randomised comparison of BC-predict versus usual screening (NCT04359420).
French DP; Astley S; Brentnall AR; Cuzick J; Dobrashian R; Duffy SW; Gorman LS; Harkness EF; Harrison F; Harvie M; Howell A; Jerrison A; Machin M; Maxwell AJ; McWilliams L; Payne K; Qureshi N; Ruane H; Sampson S; Stavrinos P; Thorpe E; Ulph F; van Staa T; Woof V; Evans DG
BMC Cancer; 2020 Jun; 20(1):570. PubMed ID: 32552763
[TBL] [Abstract][Full Text] [Related]
3. Long-term Accuracy of Breast Cancer Risk Assessment Combining Classic Risk Factors and Breast Density.
Brentnall AR; Cuzick J; Buist DSM; Bowles EJA
JAMA Oncol; 2018 Sep; 4(9):e180174. PubMed ID: 29621362
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of mammographic surveillance services in women aged 40-49 years with a moderate family history of breast cancer: a single-arm cohort study.
Duffy SW; Mackay J; Thomas S; Anderson E; Chen TH; Ellis I; Evans G; Fielder H; Fox R; Gui G; Macmillan D; Moss S; Rogers C; Sibbering M; Wallis M; Warren R; Watson E; Whynes D; Allgood P; Caunt J
Health Technol Assess; 2013 Mar; 17(11):vii-xiv, 1-95. PubMed ID: 23489892
[TBL] [Abstract][Full Text] [Related]
5. Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial.
Duffy SW; Vulkan D; Cuckle H; Parmar D; Sheikh S; Smith RA; Evans A; Blyuss O; Johns L; Ellis IO; Myles J; Sasieni PD; Moss SM
Lancet Oncol; 2020 Sep; 21(9):1165-1172. PubMed ID: 32800099
[TBL] [Abstract][Full Text] [Related]
6. Assessing the breast cancer risk distribution for women undergoing screening in British Columbia.
Weisstock CR; Rajapakshe R; Bitgood C; McAvoy S; Gordon PB; Coldman AJ; Parker BA; Wilson C
Cancer Prev Res (Phila); 2013 Oct; 6(10):1084-92. PubMed ID: 23963801
[TBL] [Abstract][Full Text] [Related]
7. Assessing individual breast cancer risk within the U.K. National Health Service Breast Screening Program: a new paradigm for cancer prevention.
Evans DG; Warwick J; Astley SM; Stavrinos P; Sahin S; Ingham S; McBurney H; Eckersley B; Harvie M; Wilson M; Beetles U; Warren R; Hufton A; Sergeant JC; Newman WG; Buchan I; Cuzick J; Howell A
Cancer Prev Res (Phila); 2012 Jul; 5(7):943-51. PubMed ID: 22581816
[TBL] [Abstract][Full Text] [Related]
8. Estimating the Breast Cancer Burden in Germany and Implications for Risk-based Screening.
Quante AS; Hüsing A; Chang-Claude J; Kiechle M; Kaaks R; Pfeiffer RM
Cancer Prev Res (Phila); 2021 Jun; 14(6):627-634. PubMed ID: 34162683
[TBL] [Abstract][Full Text] [Related]
9. Compliance with screening recommendations according to breast cancer risk levels in Izmir, Turkey.
Acikgoz A; Ergor G
Asian Pac J Cancer Prev; 2013; 14(3):1737-42. PubMed ID: 23679266
[TBL] [Abstract][Full Text] [Related]
10. Personalized prevention in high risk individuals: Managing hormones and beyond.
Evans DG; Howell SJ; Howell A
Breast; 2018 Jun; 39():139-147. PubMed ID: 29610032
[TBL] [Abstract][Full Text] [Related]
11. Estimates of the number of US women who could benefit from tamoxifen for breast cancer chemoprevention.
Freedman AN; Graubard BI; Rao SR; McCaskill-Stevens W; Ballard-Barbash R; Gail MH
J Natl Cancer Inst; 2003 Apr; 95(7):526-32. PubMed ID: 12671020
[TBL] [Abstract][Full Text] [Related]
12. Investigation of the significance of population-based breast cancer screening among women aged under 40 years.
Okazaki M; Bando H; Tohno E; Kujiraoka Y; Iguchi-Manaka A; Ichioka E; Tsushima Y; Watanabe H; Hara H
Breast Cancer; 2021 Jan; 28(1):75-81. PubMed ID: 32643018
[TBL] [Abstract][Full Text] [Related]
13. Screening women aged less than 50 years with a family history of breast cancer.
Kollias J; Sibbering DM; Blamey RW; Holland PA; Obuszko Z; Wilson AR; Evans AJ; Ellis IO; Elston CW
Eur J Cancer; 1998 May; 34(6):878-83. PubMed ID: 9797701
[TBL] [Abstract][Full Text] [Related]
14. Two-view digital breast tomosynthesis versus digital mammography in a population-based breast cancer screening programme (To-Be): a randomised, controlled trial.
Hofvind S; Holen ÅS; Aase HS; Houssami N; Sebuødegård S; Moger TA; Haldorsen IS; Akslen LA
Lancet Oncol; 2019 Jun; 20(6):795-805. PubMed ID: 31078459
[TBL] [Abstract][Full Text] [Related]
15. Influence of Risk Category and Screening Round on the Performance of an MR Imaging and Mammography Screening Program in Carriers of the BRCA Mutation and Other Women at Increased Risk.
Vreemann S; Gubern-Mérida A; Schlooz-Vries MS; Bult P; van Gils CH; Hoogerbrugge N; Karssemeijer N; Mann RM
Radiology; 2018 Feb; 286(2):443-451. PubMed ID: 29040037
[TBL] [Abstract][Full Text] [Related]
16. [The effectiveness of population-based breast cancer screening programme].
Szynglarewicz B; Matkowski R; Kasprzak P; Kotowska J; Forgacz J; Pudełko M; Kornafel J
Pol Merkur Lekarski; 2009 Feb; 26(152):117-20. PubMed ID: 19388515
[TBL] [Abstract][Full Text] [Related]
17. [Tailored Breast Screening Trial (TBST)].
Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
[TBL] [Abstract][Full Text] [Related]
18. Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2007; 7(1):1-32. PubMed ID: 23074501
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Adjunctive Ultrasonography for Breast Cancer Detection Among Women Aged 40-49 Years With Varying Breast Density Undergoing Screening Mammography: A Secondary Analysis of a Randomized Clinical Trial.
Harada-Shoji N; Suzuki A; Ishida T; Zheng YF; Narikawa-Shiono Y; Sato-Tadano A; Ohta R; Ohuchi N
JAMA Netw Open; 2021 Aug; 4(8):e2121505. PubMed ID: 34406400
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
